In contrast, this is a highly studied drug where the safety and efficacy have been demonstrated.
Measures to enhance the technique's efficacy have been identified and are currently underway.
Although some encouraging preclinical data on their anti-tumor efficacy have been reported, leflunomide and teriflunomide are weak DHODH inhibitors, with IC50s in the low µM range.
Although antidepressants are widely used in Parkinson's disease (PD), few well-designed studies to support their efficacy have been conducted.
The safety and efficacy have been demonstrated in two large phase III randomized controlled trials (IMPRESS I and IMPRESS II).
Promising signs of efficacy have been observed with CPX-351 in previously treated patients with AML with poor prognosis.
"Patients may experience adverse reactions to the bad vaccines and the immunisation programme doesn't know whether that's due to a faulty product or because quality and efficacy have been compromised".
Process kinetics and efficacy have been assessed in terms of colour, COD and TOC reductions, and also in relation to direct ozone gas contact.
The number of research reports on this topic has been increasing exponentially in the last decade but studies of clinical efficacy have been rare in recent times.
Studies on corridor efficacy have been limited to a small subset of taxa; while important, these data can rarely be extrapolated to other systems.
Enhanced safety and heightened efficacy have been achieved for a wide range of drug classes, including antitumor agents, antivirals, antifungals, antimicrobials, vaccines, and gene therapeutics.
